Cue Biopharma, Inc. (CUE) stock
CUENasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.76+1.93 (+68.20%)
Close on Nov 18, 2026Market cap $34.58MP/E –Yield –
Cue Biopharma gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Cue Biopharma
Cue Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?